Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase iii Himalaya study
Publication date:
2022
Publisher version:
Description:
European Society for Medical Oncology, ESMO Asia Congress (2022. Singapore)